Suppr超能文献

赋予抗菌药物耐药性的分子机制。

Molecular mechanisms that confer antibacterial drug resistance.

作者信息

Walsh C

机构信息

Biological Chemistry and Molecular Pharmacology Department, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Nature. 2000 Aug 17;406(6797):775-81. doi: 10.1038/35021219.

Abstract

Antibiotics--compounds that are literally 'against life'--are typically antibacterial drugs, interfering with some structure or process that is essential to bacterial growth or survival without harm to the eukaryotic host harbouring the infecting bacteria. We live in an era when antibiotic resistance has spread at an alarming rate and when dire predictions concerning the lack of effective antibacterial drugs occur with increasing frequency. In this context it is apposite to ask a few simple questions about these life-saving molecules. What are antibiotics? Where do they come from? How do they work? Why do they stop being effective? How do we find new antibiotics? And can we slow down the development of antibiotic-resistant superbugs?

摘要

抗生素——从字面意义上讲就是“抗生命”的化合物——通常是抗菌药物,它们会干扰对细菌生长或存活至关重要的某些结构或过程,而不会对携带感染细菌的真核宿主造成伤害。我们生活在一个抗生素耐药性以惊人速度蔓延的时代,而且关于缺乏有效抗菌药物的可怕预测越来越频繁地出现。在这种背景下,问几个关于这些救命分子的简单问题是恰当的。抗生素是什么?它们从何而来?它们如何发挥作用?为什么它们会失效?我们如何找到新的抗生素?以及我们能否减缓耐药超级细菌的发展?

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验